XTL BIOPHARMACEUTICALS LTD. Description Of Risk Free Interest Rate Share Options Granted
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Description Of Risk Free Interest Rate Share Options Granted of 0.19% for the 12-month period ending 2021-12-31, per its 20-F filed 2023-03-22.
Discontinued › Notes
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted · last filed 2023-03-22
| Period end | Description Of Risk Free Interest Rate Share Options Granted | Description Of Risk Free Interest Rate Share Options Granted 0 month | Description Of Risk Free Interest Rate Share Options Granted 12 month |
|---|---|---|---|
| 2021-12-31 | 0.19% 20-F · filed 2023-03-22 | ||
| 2020-12-31 | 0.12% 20-F · filed 2023-03-22 | ||
| 2019-12-31 | 1.60% 20-F · filed 2022-03-30 | ||
| 2019-01-01 | 2.48% 20-F/A · filed 2021-05-19 | ||
| 2018-03-08 | 2.61% 20-F · filed 2021-03-15 |